Oramed Pharmaceuticals News

Oramed Pharmaceuticals | 8-K: Current report

Sep 26 16:08 ET

Oramed Pharmaceuticals | 8-K: Current report

Sep 23 08:08 ET

Oramed Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BML Investment Partners, L.P.(5.0%)

Sep 16 16:47 ET

Oramed Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 14 16:13 ET

Oramed Pharmaceuticals | 8-K: Current report

Aug 2 16:12 ET

Oramed Pharmaceuticals | 8-K: Current report

Jun 26 09:03 ET

Oramed Pharmaceuticals | 8-K: Current report

Jun 24 09:05 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gabay Avraham

Jun 21 16:17 ET

Oramed Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Gabay Avraham

Jun 21 16:11 ET

Oramed Pharmaceuticals | ARS: Annual Report to Security Holders

Jun 20 07:37 ET

Oramed Pharmaceuticals | DEF 14A: Definitive information statements

Jun 20 07:32 ET

Oramed Pharmaceuticals | 8-K: Current report

Jun 10 17:30 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Reznick Yehuda

Jun 10 17:19 ET

Oramed Pharmaceuticals | 8-K: Current report

May 13 13:37 ET

Oramed Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

May 9 17:06 ET

Oramed Pharmaceuticals | 8-K: Current report

May 6 09:03 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Reznick Yehuda

Apr 18 20:12 ET

Oramed Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Reznick Yehuda

Apr 2 17:31 ET

Oramed Pharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Nadav Kidron(5.7%)

Mar 22 21:33 ET

Oramed Pharmaceuticals | 8-K: Current report

Mar 19 08:01 ET